Striant
Orchitis, Puberty, Delayed, Gonadotrophin releasing hormone deficiency + 9 more
Treatment
17 FDA approvals
3 Active Studies for Striant
Treatment for
Orchitis
What is Striant
Testosterone
The Generic name of this drug
Treatment Summary
Testosterone is a hormone that helps to develop masculine characteristics. It is prescribed to treat conditions caused by a lack of testosterone production, such as primary and secondary hypogonadism. Testosterone was first isolated from samples in 1935, and it can also be synthesized in a laboratory.
Androderm
is the brand name
Striant Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Androderm
Testosterone
1995
90
Approved as Treatment by the FDA
Testosterone, commonly known as Androderm, is approved by the FDA for 17 uses including Spermatic Cord Torsion and Puberty, Delayed .
Spermatic Cord Torsion
Helps manage Torsion of testis
Puberty, Delayed
Used to treat Puberty, Delayed in combination with Testosterone enanthate
Hypogonadism
Helps manage Hypergonadotropic Hypogonadism
Breast
Used to treat inoperable, metastatic Breast cancer in combination with Testosterone enanthate
Torsion of testis
Helps manage Torsion of testis
Hypothalamo-pituitary disorder
Helps manage Hypothalamo-pituitary disorder
Delayed Puberty
Used to treat Puberty, Delayed in combination with Testosterone enanthate
Orchitis
Helps manage Orchitis
Orchitis
Helps manage Orchitis
Hypergonadotropic Hypogonadism
Helps manage Hypergonadotropic Hypogonadism
Hypogonadotropic hypogonadism
Gonadotrophin releasing hormone deficiency
Helps manage Gonadotrophin releasing hormone deficiency
1 to 5 years post-menopausal
Used to treat 1 to 5 years post-menopausal in combination with Testosterone enanthate
Anorchia
Helps manage vanishing testis syndrome
Orchidectomy
Helps manage Orchidectomy
inoperable, metastatic Breast cancer
Used to treat inoperable, metastatic Breast cancer in combination with Testosterone enanthate
Hypogonadism
Helps manage Idiopathic Hypogonadotropic Hypogonadism
Effectiveness
How Striant Affects Patients
Testosterone helps the body create masculine sex organs and physical characteristics. Its effects last for a varying amount of time, usually 10-100 minutes. The normal level of testosterone found in an adult man is usually between 300-1000ng/dL, which is a wide range. Doctors advise patients to be careful when using testosterone products, as their children may be exposed to it.
How Striant works in the body
The androgen receptor is a molecule in the body that binds to testosterone and DHT, two hormones responsible for male sex characteristics. When these hormones bind to the androgen receptor, it triggers a chain reaction that causes changes in the body. These changes include development of the prostate, seminal vesicles, penis, and scrotum as well as facial and body hair, enlargement of the larynx, thickening of the vocal cords, and changes in muscle and fat distribution.
When to interrupt dosage
The recommended measure of Striant is contingent upon the identified condition, including Gonadotrophin releasing hormone deficiency, Orchidectomy and Orchitis. The quantity of dosage is dependent on the technique of delivery featured in the table below.
Condition
Dosage
Administration
Breast
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular
Orchitis
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular
Puberty, Delayed
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular
Gonadotrophin releasing hormone deficiency
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular
1 to 5 years post-menopausal
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular
Hypothalamo-pituitary disorder
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular
Orchidectomy
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular
Spermatic Cord Torsion
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular
Hypogonadism
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular
Hypogonadotropic hypogonadism
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular
Anorchia
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular
Hypogonadism
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular
Warnings
Striant has two contraindications and should not be used while undergoing any of the conditions described in the table below.
Striant Contraindications
Condition
Risk Level
Notes
suspected pregnancy
Do Not Combine
Breast Cancer
Do Not Combine
There are 20 known major drug interactions with Striant.
Common Striant Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Testosterone.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be increased when combined with Testosterone.
Alectinib
Major
The metabolism of Alectinib can be increased when combined with Testosterone.
Aminophylline
Major
The metabolism of Aminophylline can be increased when combined with Testosterone.
Astemizole
Major
The metabolism of Astemizole can be increased when combined with Testosterone.
Striant Toxicity & Overdose Risk
There is limited information available on what happens when someone overdoses on a topical testosterone product. However, those who overdose on an injectable testosterone product may experience a stroke-like event. Treatment for a testosterone overdose includes stopping the use of the product, washing off any topical product with soap and water, and providing supportive care.
Striant Novel Uses: Which Conditions Have a Clinical Trial Featuring Striant?
10 active trials are analyzing the potential of Striant to resolve Orchitis, Torsion of testis and Hypothalamo-pituitary Dysfunctions.
Condition
Clinical Trials
Trial Phases
Hypothalamo-pituitary disorder
0 Actively Recruiting
1 to 5 years post-menopausal
0 Actively Recruiting
Hypogonadism
0 Actively Recruiting
Orchitis
0 Actively Recruiting
Spermatic Cord Torsion
0 Actively Recruiting
Orchidectomy
0 Actively Recruiting
Breast
0 Actively Recruiting
Hypogonadotropic hypogonadism
0 Actively Recruiting
Puberty, Delayed
0 Actively Recruiting
Gonadotrophin releasing hormone deficiency
0 Actively Recruiting
Anorchia
0 Actively Recruiting
Hypogonadism
3 Actively Recruiting
Phase 2
Striant Reviews: What are patients saying about Striant?
3.7
Patient Review
1/19/2013
Striant for Undescended Testicle
3.3
Patient Review
9/17/2008
Striant for Deficient Activity of the Testis
1.7
Patient Review
1/31/2012
Striant for Deficient Activity of the Testis
Patient Q&A Section about striant
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is striant still available?
"The product is no longer available in the United States because it was discontinued."
Answered by AI
What is Striant used for?
"Striant is a prescription medication that contains testosterone. It is used to treat adult males who have low or no testosterone due to certain medical conditions."
Answered by AI
How much does striant cost?
"The cost of the drug Striant, depending on the pharmacy, is around $367 for a supply of 60. This price is for cash paying customers only and does not include insurance plans."
Answered by AI
What is testosterone buccal used for?
"Testosterone buccal systems are used to treat symptoms of low testosterone in adult men who have hypogonadism (a condition in which the body does not produce enough natural testosterone). Testosterone buccal systems are a type of medication that is inserted into the mouth and absorbs through the skin into the bloodstream."
Answered by AI